Powerful new weight-loss medications are in the works to treat obesity. Doctors explain why more options are needed and the ...

It depends. There have been a few clinical trials on the impact of GLP-1 injectable medications on weight loss with different ...

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

Discontinuing obesity medicines often means the weight comes back and people lose the cardiovascular and metabolic benefits ...

MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from ...

The Wegovy pill comes in tablet form—and is the first U.S. Food & Drug Administration (FDA)-approved GLP-1 to do so. Its ...

Use of the diabetes drug Ozempic for weight loss is rising. Understand the research, how it works, who should use it, and potential side effects.

The new oral drug costs as little as $149 a month out of pocket and is expected to broaden access as demand for GLP-1 weight-loss treatments grows.

People taking weight-loss drugs are likely to regain the weight they have lost within two years of stopping the medications, ...

Monoclonal antibodies (mAbs) aid the body against autoimmune diseases and cancer, among other things. Patients have to pick ...

Eye drop nanoparticles that shrink over time overcome the eye's natural defenses, delivering protein drugs to the retina and ...